目標定序和重測序市場 - 全球產業規模、佔有率、趨勢、機會和預測，按技術（定序、重測序）、類型、應用、最終用途、地區和競爭細分，2019-2029F

2023 年全球標靶定序和重定序市場估值為51.1 億美元，預計到2029 年預測期內將穩定成長，複合年成長率為5.25%。 ，使科學家能夠以前所未有的精確度更深入地研究遺傳變異的複雜性。這些技術在闡明疾病機制、確定治療標靶和促進個人化醫療方法方面具有巨大的前景。隨著對基因組見解的需求持續成長，在技術進步和不同領域的應用不斷增加的推動下，全球靶向測序和重測序市場出現了顯著擴張。

市場概況
預測期	2025-2029
2023 年市場規模	51.1億美元
2029 年市場規模	62.1億美元
2024-2029 年複合年成長率	5.25%
成長最快的細分市場	定序
最大的市場	北美洲

近年來，在新一代定序 (NGS) 技術的迅速採用以及對個人化醫療解決方案的日益重視的推動下，全球標靶定序和重測序市場經歷了強勁成長。標靶定序涉及選擇性地對基因組內的特定感興趣區域進行定序，與全基因組定序相比，提供更高的效率和成本效益。另一方面，重測序涉及將個體基因組與參考基因組進行比較，有助於檢測與疾病或性狀相關的遺傳變異。

主要市場促進因素

精準醫療投資的增加正在推動全球標靶定序和重測序市場

對研究工具和服務不斷成長的需求正在推動全球靶向測序和重測序市場

主要市場挑戰

數據分析與解釋

標準化和品質控制

主要市場趨勢

技術進步

細分市場洞察

技術洞察

應用洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：全球標靶定序與重定序市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依技術（定序、重定序（基於電泳的重定序、NGS、基於陣列的重定序））
  • 按類型（基於 DNA 的標靶定序、基於 RNA 的標靶定序）
  • 按應用（臨床應用、植物和動物科學、藥物開發、其他）
  • 依最終用途（醫院和診所、學術研究、其他）
  • 按地區
  • 按公司分類 (2023)
• 市場地圖
  • 依技術
  • 按類型
  • 按申請
  • 按最終用途
  • 按地區

第 5 章：亞太地區標靶定序與重定序市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依技術
  • 按類型
  • 按申請
  • 按最終用途
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 澳洲
  • 日本
  • 韓國

第 6 章：歐洲標靶定序與重定序市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依技術
  • 按類型
  • 按申請
  • 按最終用途
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 西班牙
  • 義大利
  • 英國

第 7 章：北美標靶定序與重定序市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依技術
  • 按類型
  • 按申請
  • 按最終用途
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第 8 章：南美洲標靶定序與重定序市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依技術
  • 按類型
  • 按申請
  • 按最終用途
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 9 章：中東和非洲標靶定序和重定序市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依技術
  • 按類型
  • 按申請
  • 按最終用途
  • 按國家/地區
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 10 章：市場動態

• 促進要素
• 挑戰

第 11 章：市場趨勢與發展

• 最近的發展
• 產品發布
• 併購

第 12 章：全球標靶定序與重定序市場：SWOT 分析

第 13 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第14章：競爭格局

• Agilent Technologies Inc.
• Illumina, Inc.
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific, Inc.
• DNASTAR Inc.
• Bio-Rad Laboratories, Inc.
• Integrated DNA Technologies, Inc.
• Perkin Elmer, Inc.
• RainDance Technologies, Inc.
• Genomatix Gmbh
• Macrogen, Inc.
• GATC Biotech Ag

第 15 章：策略建議

第16章調查會社について,免責事項

Global Targeted Sequencing And Resequencing Market was valued at USD 5.11 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. Targeted sequencing and resequencing have emerged as essential tools in genomics research, enabling scientists to delve deeper into the intricacies of genetic variations with unprecedented precision. These techniques hold immense promise in elucidating disease mechanisms, identifying therapeutic targets, and facilitating personalized medicine approaches. As the demand for genomic insights continues to grow, the global targeted sequencing and resequencing market witnessed significant expansion, driven by technological advancements and increasing applications across diverse sectors.

Market Overview
Forecast Period	2025-2029
Market Size 2023	USD 5.11 Billion
Market Size 2029	USD 6.21 Billion
CAGR 2024-2029	5.25%
Fastest Growing Segment	Sequencing
Largest Market	North America

The global targeted sequencing and resequencing market has experienced robust growth in recent years, propelled by the burgeoning adoption of next-generation sequencing (NGS) technologies and a rising emphasis on personalized healthcare solutions. Targeted sequencing involves selectively sequencing specific regions of interest within the genome, offering enhanced efficiency and cost-effectiveness compared to whole-genome sequencing. On the other hand, resequencing involves the comparison of an individual's genome to a reference genome, facilitating the detection of genetic variations associated with diseases or traits.

Key Market Drivers

Rising Investments in Precision Medicine is Driving the Global Targeted Sequencing And Resequencing Market

Precision medicine, a groundbreaking approach that tailors medical treatment to individual characteristics, is revolutionizing healthcare. At the forefront of this revolution is targeted sequencing and resequencing, technologies that allow for the precise analysis of genetic information. As investments in precision medicine soar, the global targeted sequencing and resequencing market is experiencing unprecedented growth. Precision medicine represents a paradigm shift in healthcare, moving away from the traditional one-size-fits-all approach to treatments and diagnostics. By leveraging advances in genomics, proteomics, and other omics technologies, precision medicine seeks to understand the unique genetic makeup of each patient and tailor medical interventions accordingly. This personalized approach holds the promise of more effective treatments with fewer side effects, ultimately improving patient outcomes.

At the heart of precision medicine lies the ability to accurately sequence and analyze the genome. Targeted sequencing and resequencing are powerful techniques that enable researchers and clinicians to examine specific regions of the genome with unparalleled precision. Targeted sequencing focuses on sequencing predetermined regions of interest, such as genes associated with specific diseases or drug responses. Resequencing, on the other hand, involves comparing an individual's genome to a reference genome to identify variations or mutations.

Growing Demand for Research Tools and Services is Driving the Global Targeted Sequencing And Resequencing Market

Genomic research has become integral to various scientific disciplines, including healthcare, agriculture, forensics, and evolutionary biology. The ability to sequence and analyze specific regions of the genome with high accuracy and efficiency has revolutionized our understanding of genetic variations, disease mechanisms, and evolutionary relationships. Targeted sequencing and resequencing techniques, such as polymerase chain reaction (PCR) amplification, hybridization capture, and amplicon sequencing, have significantly contributed to advancing genomic studies by allowing researchers to focus on specific regions of interest.

With the growing emphasis on personalized medicine, there is an increasing need to identify genetic variants associated with diseases, drug responses, and treatment outcomes. Targeted sequencing facilitates the identification of relevant genetic markers with high specificity and sensitivity, paving the way for tailored therapeutic interventions. Cancer is a genetically heterogeneous disease characterized by complex molecular alterations. Targeted sequencing enables comprehensive profiling of cancer genomes, leading to the discovery of driver mutations, assessment of tumor heterogeneity, and identification of potential therapeutic targets. As precision oncology gains traction, the demand for targeted sequencing in cancer research and clinical diagnostics continues to rise.

In agriculture, targeted sequencing plays a crucial role in crop improvement, livestock breeding, and biodiversity conservation. By analyzing specific genomic regions associated with desirable traits such as yield, disease resistance, and nutritional content, researchers can accelerate the development of genetically superior crops and livestock breeds, contributing to global food security and sustainability. Rapid and accurate detection of pathogens is essential for disease surveillance, outbreak investigation, and public health response. Targeted sequencing enables the selective amplification and sequencing of microbial genomes, facilitating the identification and characterization of infectious agents, including bacteria, viruses, and parasites. This capability is particularly valuable in monitoring emerging infectious diseases and tracking transmission dynamics.

Key Market Challenges

Data Analysis and Interpretation

Another significant hurdle in the global targeted sequencing and resequencing market is the complexity of data analysis and interpretation. The massive amount of sequencing data generated from these techniques requires sophisticated bioinformatics tools and expertise to extract meaningful insights. Analyzing sequencing data involves various steps, including read alignment, variant calling, and annotation, each of which presents its own set of challenges.

To address this issue, there is a growing demand for user-friendly bioinformatics software that can streamline data analysis workflows and provide actionable results. Additionally, there is a need for specialized training programs and workshops to educate researchers and clinicians on best practices for data analysis and interpretation.

Standardization and Quality Control

Ensuring the accuracy and reproducibility of sequencing results is crucial for the success of targeted sequencing and resequencing applications, particularly in clinical settings where decisions regarding patient care may be based on sequencing data. However, achieving consistent results across different sequencing platforms and laboratories remains a significant challenge due to the lack of standardized protocols and quality control measures.

Industry organizations and regulatory agencies play a vital role in addressing this challenge by developing guidelines and standards for sample preparation, sequencing protocols, and data analysis pipelines. Additionally, the implementation of rigorous quality control measures, such as regular performance monitoring and proficiency testing, can help ensure the reliability of sequencing results.

Key Market Trends

Technological Advancements

In recent years, the field of genomics has witnessed a rapid evolution, driven largely by advancements in sequencing technologies. One of the most significant developments in this realm is targeted sequencing and resequencing, which allows researchers to focus on specific regions of the genome with high precision and accuracy. This technology has revolutionized various aspects of genetic research, including disease diagnosis, drug discovery, and personalized medicine. As a result, the global targeted sequencing and resequencing market is experiencing substantial growth, propelled by the increasing demand for efficient and cost-effective genomic analysis tools.

Targeted sequencing involves the selective amplification and sequencing of specific regions of interest within the genome. This approach offers several advantages over whole-genome sequencing, including reduced costs, faster turnaround times, and higher sequencing depth, leading to greater sensitivity for detecting genetic variations. By targeting only relevant genomic regions, researchers can efficiently interrogate specific genes or genomic regions associated with particular diseases or traits.

Resequencing, on the other hand, involves the comparison of an individual's genome to a reference genome to identify genetic variations, such as single nucleotide polymorphisms (SNPs), insertions, deletions, and structural variants. This enables researchers to study genetic diversity within populations, identify disease-causing mutations, and understand the genetic basis of complex traits.

The growing adoption of targeted sequencing and resequencing technologies can be attributed to several factors. Firstly, advancements in sequencing platforms, such as next-generation sequencing (NGS) and third-generation sequencing technologies, have significantly enhanced the speed, accuracy, and cost-effectiveness of genomic analysis. These platforms offer higher throughput, increased read lengths, and improved sequencing chemistry, allowing researchers to generate large volumes of sequencing data with unprecedented accuracy and resolution.

Furthermore, the development of innovative library preparation methods, sequencing chemistries, and bioinformatics tools has further streamlined the targeted sequencing and resequencing workflow, making it more accessible to researchers with diverse backgrounds and expertise. Additionally, collaborations between academia, industry, and government agencies have facilitated the translation of genomic research findings into clinical applications, driving the adoption of targeted sequencing and resequencing in healthcare settings.

The applications of targeted sequencing and resequencing are vast and encompass various fields, including medical genetics, oncology, agriculture, and forensics. In medical genetics, targeted sequencing is used for the diagnosis of inherited diseases, pharmacogenomics, and prenatal screening. In oncology, targeted sequencing plays a crucial role in identifying somatic mutations associated with cancer development, predicting treatment response, and monitoring disease progression. In agriculture, targeted sequencing is utilized for crop improvement, trait mapping, and biodiversity conservation. In forensics, targeted sequencing is employed for human identification, paternity testing, and forensic DNA analysis.

Segmental Insights

Technology Insights

Based on the category of technology, Sequencing emerged as the dominant segment in the global market for Targeted Sequencing And Resequencing in 2023. Sequencing technologies have experienced a rapid evolution, characterized by increased throughput, enhanced accuracy, and reduced costs. These advancements have empowered researchers with the ability to efficiently analyze specific regions of the genome, facilitating targeted sequencing and resequencing endeavors. Next-generation sequencing (NGS) has emerged as a cornerstone technology in the field of genomics. Its high-throughput capabilities and cost-effectiveness have democratized genomic research, enabling widespread adoption across academic, clinical, and industrial sectors. NGS platforms such as Illumina's HiSeq, NovaSeq, and MiSeq have become synonymous with targeted sequencing applications, empowering researchers to explore genetic variations with unprecedented depth and scale.

Application Insights

The Clinical application segment is projected to experience rapid growth during the forecast period. Targeted sequencing enables precise analysis of specific genomic regions associated with diseases. This capability is pivotal in advancing precision medicine initiatives, where treatments are tailored to individual genetic profiles. As precision medicine gains prominence, the demand for targeted sequencing in clinical settings escalates. Targeted sequencing facilitates accurate diagnosis of genetic disorders and provides insights into disease risk assessment. Clinicians utilize this technology to identify mutations responsible for various ailments, enabling early detection and intervention. Consequently, targeted sequencing has become integral to clinical diagnostics, driving its adoption in healthcare institutions worldwide.

Regional Insights

North America emerged as the dominant region in the global Targeted Sequencing And Resequencing market in 2023, holding the largest market share in terms of value. North America, particularly the United States and Canada, boasts a robust ecosystem of biotechnology companies, research institutions, and academic centers focused on genomics. These entities have invested heavily in cutting-edge technologies for targeted sequencing and resequencing, driving innovation and market growth. With ample funding and resources, North American companies and research organizations lead the way in developing advanced sequencing platforms, bioinformatics tools, and applications for genomic analysis.

Key Market Players

Agilent Technologies Inc.

Illumina, Inc.

F. Hoffmann-La Roche Ltd

Thermo Fisher Scientific, Inc.

DNASTAR Inc.

Bio-Rad Laboratories, Inc.

Integrated DNA Technologies, Inc.

Perkin Elmer, Inc.

RainDance Technologies, Inc.

Genomatix GmbH

Macrogen, Inc.

GATC Biotech Ag

Report Scope:

In this report, the Global Targeted Sequencing And Resequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Targeted Sequencing And Resequencing Market, By Technology:

Sequencing Re-sequencing

Targeted Sequencing And Resequencing Market, By Type:

DNA-based targeted sequencing RNA-based targeted sequencing

Targeted Sequencing And Resequencing Market, By Application:

Clinical application Plant and animal sciences Drug development Others

Targeted Sequencing And Resequencing Market, By End - use:

Hospitals & clinics Academic research Others

Targeted Sequencing And Resequencing Market, By Region:

North America
• United States
• Canada
• Mexico
Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
South America
• Brazil
• Argentina
• Colombia
Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Targeted Sequencing And Resequencing Market.

Available Customizations:

Global Targeted Sequencing And Resequencing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Targeted Sequencing And Resequencing Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Technology (Sequencing, Re-sequencing( Electrophoresis-based resequencing, NGS, Array-based resequencing))
  • 4.2.2. By Type (DNA-based targeted sequencing, RNA-based targeted sequencing)
  • 4.2.3. By Application (Clinical application, Plant and animal sciences, Drug development, Others)
  • 4.2.4. By End use (Hospitals & clinics, Academic research, Others)
  • 4.2.5. By Region
  • 4.2.6. By Company (2023)
• 4.3. Market Map
  • 4.3.1. By Technology
  • 4.3.2. By Type
  • 4.3.3. By Application
  • 4.3.4. By End use
  • 4.3.5. By Region

5. Asia Pacific Targeted Sequencing And Resequencing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology
  • 5.2.2. By Type
  • 5.2.3. By Application
  • 5.2.4. By End use
  • 5.2.5. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Targeted Sequencing And Resequencing Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Technology
      • 5.3.1.2.2. By Type
      • 5.3.1.2.3. By Application
      • 5.3.1.2.4. By End use
  • 5.3.2. India Targeted Sequencing And Resequencing Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Technology
      • 5.3.2.2.2. By Type
      • 5.3.2.2.3. By Application
      • 5.3.2.2.4. By End use
  • 5.3.3. Australia Targeted Sequencing And Resequencing Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Technology
      • 5.3.3.2.2. By Type
      • 5.3.3.2.3. By Application
      • 5.3.3.2.4. By End use
  • 5.3.4. Japan Targeted Sequencing And Resequencing Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Technology
      • 5.3.4.2.2. By Type
      • 5.3.4.2.3. By Application
      • 5.3.4.2.4. By End use
  • 5.3.5. South Korea Targeted Sequencing And Resequencing Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Technology
      • 5.3.5.2.2. By Type
      • 5.3.5.2.3. By Application
      • 5.3.5.2.4. By End use

6. Europe Targeted Sequencing And Resequencing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End use
  • 6.2.5. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Targeted Sequencing And Resequencing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End use
  • 6.3.2. Germany Targeted Sequencing And Resequencing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End use
  • 6.3.3. Spain Targeted Sequencing And Resequencing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End use
  • 6.3.4. Italy Targeted Sequencing And Resequencing Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Technology
      • 6.3.4.2.2. By Type
      • 6.3.4.2.3. By Application
      • 6.3.4.2.4. By End use
  • 6.3.5. United Kingdom Targeted Sequencing And Resequencing Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Technology
      • 6.3.5.2.2. By Type
      • 6.3.5.2.3. By Application
      • 6.3.5.2.4. By End use

7. North America Targeted Sequencing And Resequencing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End use
  • 7.2.5. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Targeted Sequencing And Resequencing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End use
  • 7.3.2. Mexico Targeted Sequencing And Resequencing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End use
  • 7.3.3. Canada Targeted Sequencing And Resequencing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End use

8. South America Targeted Sequencing And Resequencing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End use
  • 8.2.5. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Targeted Sequencing And Resequencing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End use
  • 8.3.2. Argentina Targeted Sequencing And Resequencing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End use
  • 8.3.3. Colombia Targeted Sequencing And Resequencing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End use

9. Middle East and Africa Targeted Sequencing And Resequencing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End use
  • 9.2.5. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Targeted Sequencing And Resequencing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End use
  • 9.3.2. Saudi Arabia Targeted Sequencing And Resequencing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End use
  • 9.3.3. UAE Targeted Sequencing And Resequencing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End use

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Targeted Sequencing And Resequencing Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Agilent Technologies Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Product & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Illumina, Inc.
• 14.3. F. Hoffmann-La Roche Ltd
• 14.4. Thermo Fisher Scientific, Inc.
• 14.5. DNASTAR Inc.
• 14.6. Bio-Rad Laboratories, Inc.
• 14.7. Integrated DNA Technologies, Inc.
• 14.8. Perkin Elmer, Inc.
• 14.9. RainDance Technologies, Inc.
• 14.10. Genomatix Gmbh
• 14.11. Macrogen, Inc.
• 14.12. GATC Biotech Ag

15. Strategic Recommendations

16. About Us & Disclaimer